Detalhe da pesquisa
1.
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
Nature
; 612(7940): 540-545, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323336
2.
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Nature
; 602(7896): 300-306, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823256
3.
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.
Nature
; 607(7917): 119-127, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576972
4.
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
Nature
; 603(7902): 687-692, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062015
5.
Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
BMC Microbiol
; 24(1): 6, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172680
6.
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
Epidemiol Infect
; 152: e24, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258464
7.
Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.
J Infect Chemother
; 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242284
8.
Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
Proc Natl Acad Sci U S A
; 118(27)2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140350
9.
Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
J Virol
; 96(4): e0155121, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818068
10.
Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
Virol J
; 20(1): 146, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443091
11.
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Proc Natl Acad Sci U S A
; 117(28): 16587-16595, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571934
12.
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
Emerg Infect Dis
; 28(11): 2198-2205, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198306
13.
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
N Engl J Med
; 388(1): 89-91, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476720
14.
Accuracy of rapid antigen detection test for nasopharyngeal swab specimens and saliva samples in comparison with RT-PCR and viral culture for SARS-CoV-2 detection.
J Infect Chemother
; 27(7): 1058-1062, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934920
15.
Pathogenesis of Influenza A(H7N9) Virus in Aged Nonhuman Primates.
J Infect Dis
; 222(7): 1155-1164, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433769
16.
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
N Engl J Med
; 386(10): 995-998, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081300
17.
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
N Engl J Med
; 386(15): 1475-1477, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263535
18.
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.
N Engl J Med
; 387(22): 2094-2097, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383452
19.
Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection.
J Virol
; 92(4)2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212926
20.
Characterization of H7N9 influenza A viruses isolated from humans.
Nature
; 501(7468): 551-5, 2013 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23842494